Zhejiang Yongtai

MAY 1, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Gabapentin (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for gabapentin labeling; it documents a regulatory decision but does not report clinical trial data or efficacy outcomes.